✦ LIBER ✦

Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone

✍ Scribed by Joel B. Nelson; Karim Fizazi; Kurt Miller; Celestia Higano; Judd W. Moul; Hideyuki Akaza; Thomas Morris; Stuart McIntosh; Kristine Pemberton; Martin Gleave

Book ID: 112067245
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 846 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of zibotentan (ZD4054) i

A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer

✍ William R. Schelman; Glenn Liu; George Wilding; Thomas Morris; De Phung; Robert 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 153 KB

Final safety and efficacy analysis of th

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial

✍ Nicholas D. James; Armelle Caty; Heather Payne; Michael Borre; Bernard A. Zonnen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Randomized phase II study of danusertib

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vita 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Denosumab and bone-metastasis-free survi

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

✍ Matthew R Smith; Fred Saad; Robert Coleman; Neal Shore; Karim Fizazi; Bertrand T 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 216 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

Re: Denosumab and Bone-Metastasis-Free S

Re: Denosumab and Bone-Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 115 KB